GROUP LEADER

Stefan Alig, MD

Senior Attending Physician & Max-Eder Research Group Leader

Department of Hematology and Stem Cell Transplantation
University Hospital Essen · Germany

About Stefan Alig

Stefan Alig is a hematologist and medical oncologist at University Hospital Essen, where he has served as Senior Attending Physician and Max-Eder Research Group Leader since 2025.

He trained at LMU Munich and spent five years as a postdoctoral research fellow at Stanford University with Ash A. Alizadeh and Maximilian Diehn. His work focuses on liquid biopsy, molecular classification, and precision oncology in lymphoma.

Career & research training

2025–present: University Hospital Essen
Senior Attending Physician and Max-Eder Research Group Leader, Department of Hematology and Stem Cell Transplantation.
2023–2024: LMU University Hospital Munich
Research Group Leader and Clinical Fellow in Hematology and Oncology, Department of Medicine III.
2018–2023: Stanford University
Postdoctoral Research Fellow, Division of Oncology. Laboratories of Ash A. Alizadeh and Maximilian Diehn.
2013–2018: LMU University Hospital Munich
Clinical and research training, Department of Medicine III.

Qualifications

2026 — Habilitation in Internal Medicine, University of Duisburg-Essen; qualification for university teaching (venia legendi).
2025 — Specialist certification in Internal Medicine, Hematology and Medical Oncology.
2014 — Medical doctorate, LMU Munich, magna cum laude.
2013 — Medical degree and German State Examination, LMU Munich.

Selected awards & fellowships

2026 — Walter Siegenthaler Silver Medal.
2025 — EHA-ASH Translational Research Training in Hematology (TRTH scholar).
2021 — German Lymphoma Alliance Award for Lymphoma Clinical Research.
2018 — Mildred Scheel Postdoctoral Fellowship, German Cancer Aid.